Sabby Management
Latest statistics and disclosures from Sabby Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Ishares Tr Index option, Spdr S&p 500 Etf Tr option, IWM, SPY, Apricus Biosciences, and represent 87.62% of Sabby Management's stock portfolio.
- Added to shares of these 10 stocks: Spdr S&p 500 Etf Tr option (+$20M), IWM (+$13M), SPY, Apricus Biosciences, TNXP, DUO, Aptevo Therapeutics, EZGO, BLRX, CKPT.
- Started 30 new stock positions in PMCB, DUO, BCLI, Aptevo Therapeutics, Apricus Biosciences, NCRA, Meta Materials, SPY, BJDX, Tingo Group.
- Reduced shares in these 10 stocks: Akari Therapeutics (-$29M), Brainstorm Cell Therapeutics call (-$25M), Ishares Tr Index option, Sonnet Biotherapeutics Holdings Ord, Sidus Space Inc Class A, ITRM, SHFS, ATXI, Reviva Pharmaceutcls Hldgs I, SHOT.
- Sold out of its positions in Aditxt, FUV, Ascent Solar Technologies, IONM, ATXI, Bone Biologics Corp, Bridgebio Pharma Inc call, Bright Green Corp, COSM, EDBL.
- Sabby Management was a net seller of stock by $-26M.
- Sabby Management has $137M in assets under management (AUM), dropping by 11.78%.
- Central Index Key (CIK): 0001535610
Tip: Access up to 7 years of quarterly data
Positions held by Sabby Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sabby Management
Sabby Management holds 84 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ishares Tr Etf Put Option | 42.8 | $59M | -2% | 3.3k | 17674.00 |
|
| SPDR S&P 500 Etf Put Option | 31.9 | $44M | +81% | 1.0k | 42748.00 |
|
| Ishares Tr Etf (IWM) | 9.4 | $13M | NEW | 73k | 176.74 |
|
| SPDR S&P 500 Etf (SPY) | 1.9 | $2.6M | NEW | 6.0k | 427.47 |
|
| Apricus Biosciences | 1.6 | $2.2M | NEW | 12M | 0.18 |
|
| Tuanche Ads | 0.7 | $951k | -8% | 1.8M | 0.52 |
|
| Recon Technology Cl A (RCON) | 0.7 | $919k | -5% | 3.0M | 0.31 |
|
| Biora Therapeutics Ord (BIOR) | 0.6 | $817k | -21% | 377k | 2.17 |
|
| Akari Therapeutics Adr | 0.5 | $704k | -97% | 178k | 3.95 |
|
| Tonix Pharmaceuticals Hldg (TNXP) | 0.5 | $680k | NEW | 1.2M | 0.55 |
|
| Reviva Pharmaceutcls Hldgs I Put Option | 0.4 | $549k | +18% | 1.1k | 488.00 |
|
| Reviva Pharmaceutcls Hldgs I Call Option | 0.4 | $536k | -52% | 1.1k | 488.00 |
|
| Nisun Intl Ent Dvpmt Gp SHS (NISN) | 0.4 | $528k | -8% | 221k | 2.39 |
|
| Integrity Applications (GCTK) | 0.4 | $526k | 2.0M | 0.26 |
|
|
| Dogness Intl Corp Cl A | 0.4 | $519k | -5% | 1.1M | 0.47 |
|
| Biolinerx Adr Put Option | 0.4 | $504k | +154% | 2.8k | 182.00 |
|
| Fangdd Network Group Ads (DUO) | 0.4 | $479k | NEW | 622k | 0.77 |
|
| Briacell Therapeutics Corp Put Option | 0.3 | $445k | -16% | 712.00 | 625.00 |
|
| Aptevo Therapeutics | 0.3 | $440k | NEW | 1.3M | 0.33 |
|
| Soligenix (SNGX) | 0.3 | $413k | -9% | 741k | 0.56 |
|
| Ezgo Technologies SHS (EZGO) | 0.3 | $406k | NEW | 2.8M | 0.14 |
|
| Biolinerx Adr (BLRX) | 0.3 | $382k | NEW | 210k | 1.82 |
|
| Checkpoint Therapeutics (CKPT) | 0.3 | $349k | NEW | 205k | 1.70 |
|
| Redhill Biopharma Ads (RDHL) | 0.2 | $324k | NEW | 635k | 0.51 |
|
| Pulmatrix (PULM) | 0.2 | $307k | -17% | 151k | 2.03 |
|
| Toughbuilt Inds | 0.2 | $297k | NEW | 1.5M | 0.20 |
|
| Bit Brother Cl A | 0.2 | $291k | -37% | 567k | 0.51 |
|
| Revelation Biosciences | 0.2 | $278k | +14% | 403k | 0.69 |
|
| Allarity Therapeutics (ALLR) | 0.2 | $269k | NEW | 359k | 0.75 |
|
| Neptune Wellness Solutions I (NEPTF) | 0.2 | $247k | NEW | 187k | 1.32 |
|
| Phio Pharmaceuticals (PHIO) | 0.2 | $236k | 156k | 1.51 |
|
|
| Virpax Pharmaceuticals | 0.2 | $234k | -26% | 293k | 0.80 |
|
| Harbor Custom Development In (HCDIQ) | 0.2 | $232k | +6% | 165k | 1.41 |
|
| Gamida Cell SHS Put Option | 0.2 | $231k | 2.2k | 103.00 |
|
|
| Bit Digital SHS Put Option | 0.2 | $223k | +552% | 1.0k | 214.00 |
|
| Reviva Pharmaceutcls Hldgs I (RVPH) | 0.2 | $218k | NEW | 45k | 4.88 |
|
| Scinai Immunotherapeutics Ads (SCNI) | 0.2 | $213k | +28% | 245k | 0.87 |
|
| Pharmacyte Biotech (PMCB) | 0.1 | $204k | NEW | 97k | 2.10 |
|
| Marpai (MRAI) | 0.1 | $198k | -20% | 299k | 0.66 |
|
| Invo Bioscience Incorporated (INVO) | 0.1 | $183k | NEW | 231k | 0.79 |
|
| Gevo Inc call Call Option | 0.1 | $142k | +181% | 1.2k | 119.00 |
|
| Netcapital (NCPL) | 0.1 | $137k | -12% | 334k | 0.41 |
|
| Ensysce Biosciences (ENSC) | 0.1 | $134k | -69% | 97k | 1.38 |
|
| Transcode Therapeutics | 0.1 | $126k | +32% | 250k | 0.50 |
|
| Bright Green Corp (BGXX) | 0.1 | $120k | NEW | 304k | 0.40 |
|
| Gamida Cell SHS (GMDA) | 0.1 | $115k | +88% | 111k | 1.03 |
|
| Arcadia Biosciences (RKDA) | 0.1 | $110k | -72% | 33k | 3.35 |
|
| 60 Degrees Pharmaceuticals *W (SXTPW) | 0.1 | $107k | NEW | 307k | 0.35 |
|
| Amplitech Group *W (AMPGW) | 0.1 | $102k | 416k | 0.24 |
|
|
| Mobiquity Technologies (MOBQ) | 0.1 | $97k | NEW | 144k | 0.67 |
|
| Cingulate *W (CINGW) | 0.1 | $93k | 566k | 0.17 |
|
|
| Bluejay Diagnostics (BJDX) | 0.1 | $92k | NEW | 21k | 4.33 |
|
| Nrx Pharmaceuticals (NRXP) | 0.1 | $85k | -53% | 325k | 0.26 |
|
| Forza X1 (FRZA) | 0.1 | $84k | -73% | 103k | 0.81 |
|
| Troika Media Group (TRKAQ) | 0.1 | $83k | +37% | 75k | 1.10 |
|
| Bullfrog Ai Holdings *W (BFRGW) | 0.1 | $82k | -9% | 145k | 0.57 |
|
| Sphere 3d Corp Call Option | 0.1 | $75k | 565.00 | 133.00 |
|
|
| Wearable Devices *W (WLDSW) | 0.1 | $71k | -41% | 673k | 0.11 |
|
| Brainstorm Cell Therapeutics call Call Option | 0.0 | $61k | -99% | 3.0k | 20.01 |
|
| Vincera Pharma (VINC) | 0.0 | $58k | -44% | 57k | 1.01 |
|
| Infobird Ord | 0.0 | $53k | +1991% | 500k | 0.11 |
|
| Applied Dna Sciences (APDN) | 0.0 | $47k | NEW | 39k | 1.21 |
|
| Applied Dna Sciences Inc put Put Option | 0.0 | $47k | NEW | 389.00 | 121.00 |
|
| Smart For Life | 0.0 | $45k | NEW | 55k | 0.82 |
|
| Nocera (NCRA) | 0.0 | $44k | NEW | 29k | 1.52 |
|
| Lexaria Bioscience Corp *W (LEXXW) | 0.0 | $42k | -12% | 210k | 0.20 |
|
| Esports Entmt Group *W (GMBLZ) | 0.0 | $37k | 4.6M | 0.01 |
|
|
| Castor Maritime Put Option | 0.0 | $36k | 824.00 | 43.70 |
|
|
| Castor Maritime | 0.0 | $36k | 82k | 0.44 |
|
|
| Brainstorm Cell Therapeutics (BCLI) | 0.0 | $27k | NEW | 137k | 0.20 |
|
| Canaan Call Option | 0.0 | $26k | 141.00 | 182.00 |
|
|
| Dogness Intl Corp Cl A Call Option | 0.0 | $25k | -42% | 534.00 | 47.00 |
|
| Greenwave Technology Solutio (GWAV) | 0.0 | $21k | NEW | 31k | 0.68 |
|
| G Med Innovations Hldgs SHS (GMVDF) | 0.0 | $20k | -48% | 353k | 0.06 |
|
| 9 Meters Biopharma Ord (NMTRQ) | 0.0 | $20k | +61% | 1.7M | 0.01 |
|
| Bruush Oral Care *W (BRSHW) | 0.0 | $19k | +2% | 552k | 0.03 |
|
| Tingo Group Put Option | 0.0 | $15k | NEW | 148.00 | 102.50 |
|
| Innovative Eyewear *W (LUCYW) | 0.0 | $14k | 105k | 0.13 |
|
|
| Ocean Pwr Technologies (OPTT) | 0.0 | $10k | 27k | 0.39 |
|
|
| Meta Materials Put Option | 0.0 | $10k | NEW | 474.00 | 21.19 |
|
| Arqit Quantum Ord (ARQQ) | 0.0 | $8.1k | NEW | 14k | 0.59 |
|
| C3is (CISS) | 0.0 | $4.7k | NEW | 10k | 0.46 |
|
| Jeffs Brands *W (JFBRW) | 0.0 | $2.7k | 77k | 0.04 |
|
|
| Brainstorm Cell Therapeutics put Put Option | 0.0 | $2.1k | 106.00 | 20.01 |
|
Past Filings by Sabby Management
SEC 13F filings are viewable for Sabby Management going back to 2012
- Sabby Management 2023 Q3 filed Nov. 14, 2023
- Sabby Management 2023 Q2 filed Aug. 14, 2023
- Sabby Management 2023 Q1 filed May 15, 2023
- Sabby Management 2022 Q4 filed Feb. 14, 2023
- Sabby Management 2022 Q3 filed Nov. 14, 2022
- Sabby Management 2022 Q2 filed Aug. 15, 2022
- Sabby Management 2022 Q1 filed May 16, 2022
- Sabby Management 2021 Q4 filed Feb. 14, 2022
- Sabby Management 2021 Q3 filed Nov. 15, 2021
- Sabby Management 2021 Q2 filed Aug. 16, 2021
- Sabby Management 2021 Q1 filed May 17, 2021
- Sabby Management 2020 Q4 filed Feb. 16, 2021
- Sabby Management 2020 Q3 filed Nov. 16, 2020
- Sabby Management 2020 Q2 filed Aug. 14, 2020
- Sabby Management 2020 Q1 filed May 15, 2020
- Sabby Management 2019 Q4 filed Feb. 14, 2020